An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

CompletedOBSERVATIONAL

Enrollment

22,960

Participants

Timeline

Start Date

June 24, 2002

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Growth Hormone DisorderPituitary DwarfismHypopituitarism

Interventions

DRUG

somatropin

Safety and effectiveness data collection in connection with the use of Norditropin® (somatropin) in daily clinical practice

Trial Locations (1)

Novo Nordisk Investigational Site, Plainsboro